GMT Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.84M Hold
1,305,200
0.36% 25
2026
Q1
$2.3M Buy
+1,305,200
New +$2.83M 0.1% 48
2025
Q4
Sell
-1,305,200
Closed -$3.99M 50
2025
Q3
$3.99M Hold
1,305,200
0.18% 37
2025
Q2
$3.64M Hold
1,305,200
0.15% 43
2025
Q1
$4.69M Buy
+1,305,200
New +$5.24M 0.25% 36
2024
Q4
Sell
-1,305,200
Closed -$3.68M 66
2024
Q3
$3.68M Hold
1,305,200
0.15% 40
2024
Q2
$1.61M Hold
1,305,200
0.06% 50
2024
Q1
$1.04M Buy
+1,305,200
New +$1.19M 0.04% 46
2023
Q4
Sell
-1,305,200
Closed -$1.41M 63
2023
Q3
$1.41M Hold
1,305,200
0.05% 79
2023
Q2
$1.17M Buy
+1,305,200
New +$1.16M 0.04% 68
2023
Q1
Sell
-310,800
Closed -$289K 88
2022
Q4
$289K Hold
310,800
0.01% 60
2022
Q3
$528K Hold
310,800
0.03% 82
2022
Q2
$665K Hold
310,800
0.04% 75
2022
Q1
$1.1M Buy
+310,800
New +$901K 0.07% 62

Other funds holding CLOV

GMT Capital's CLOV Position: Q2 2026 in Review

GMT Capital held its Clover Health Investments (CLOV) position steady in Q2 2026 at 1,305,200 shares worth $6.84M. The position accounts for 0.36% of the portfolio, ranked #25.

GMT Capital first reported a position in CLOV in Q1 2022 and has held it in 14 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • GMT Capital held 1,305,200 shares of Clover Health Investments worth $6.84M as of Q2 2026.
  • GMT Capital left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up 0.36% of GMT Capital's portfolio in Q2 2026, its #25 holding.
  • GMT Capital first reported a position in Clover Health Investments in Q1 2022 and has held it in 14 quarters since.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on GMT Capital's 13F filing for Q2 2026, filed 14 Aug 2026.